Fungal components of the feline gut microbiome: beyond bacteria

The feline gut microbiome is often discussed as a bacterial ecosystem, yet bacteria represent only one part of a complex microbial community. Fungi, yeasts and other eukaryotic organisms may influence nutrient metabolism, immune signalling and the stability of the intestinal environment in cats.

The mycobiome—the fungal component of the microbiota—remains less clearly characterised than the bacterial microbiome. This is partly because fungal DNA is present in smaller quantities, methods vary between studies, and results can be strongly affected by diet, medication, age, sampling site and laboratory technique.

For veterinary professionals, this field offers a wider perspective on dysbiosis and chronic enteropathy. A change in fungal abundance may be a cause, a consequence or simply a marker of altered intestinal conditions, so interpretation requires clinical context rather than a single test result.

The Hills ActivBiome educational platform brings this developing science into practical veterinary discussion through expert presentations, webinar recordings and downloadable resources. Its focus on feline and canine gut health supports clinicians seeking a more complete understanding of microbiome-informed nutrition.

What the feline mycobiome includes

Fungal communities in cats may include yeasts such as Candida and Saccharomyces, alongside filamentous fungi detected at lower levels. Some organisms may be transient dietary passengers, while others can persist within the gastrointestinal tract and interact with epithelial cells, mucus, bacteria and host immunity.

The composition of this community is likely shaped by intestinal pH, oxygen availability, bile acids, fibre fermentation and the supply of carbohydrates and other substrates. These factors create ecological niches in which fungal organisms may expand or contract as the broader gut environment changes.

How fungi interact with bacteria

Fungi and bacteria compete for nutrients and attachment sites, but they can also cooperate through cross-feeding and shared metabolic networks. Yeasts may consume oxygen or release metabolites that alter bacterial growth, while bacterial fermentation products can affect fungal survival and gene expression.

This relationship matters when evaluating dysbiosis. A bacterial shift may be accompanied by a change in fungal populations, but the two patterns do not always move together. A low bacterial diversity score, for example, does not automatically indicate a harmful fungal overgrowth.

Relevance to chronic enteropathies

Cats with chronic enteropathy may experience altered barrier function, immune activation, vomiting, diarrhoea, weight loss or appetite changes. These clinical signs can modify the gut habitat through reduced food intake, rapid dietary changes, antimicrobial exposure and changes in intestinal transit.

Fungal signals in affected cats should therefore be viewed alongside history, physical examination, bloodwork, imaging, faecal assessment and response to dietary therapy. Current evidence does not support treating every detectable fungus as a pathogen. The important question is whether a microbial change aligns with inflammation, barrier disruption and clinical disease.

Diet as an ecological influence

Diet provides the substrates that shape microbial metabolism. Protein sources, fermentable fibre, fat content, digestible carbohydrate and the physical form of a food can all influence the intestinal ecosystem. Dietary starch, for instance, may affect faecal microbial profiles in cats with diabetes, as discussed in this analysis of dietary starch sources.

This does not mean that a single ingredient determines fungal health. The total nutrient profile, feeding consistency and the individual cat’s tolerance are more clinically meaningful. In Australian practice, dietary advice may also need to account for the popularity of premium foods, raw feeding customs and frequent switching between imported and locally available products.

Medication and environmental pressures

Antibiotics can disrupt bacterial competitors and alter the resources available to yeasts and other fungi. Corticosteroids, acid-suppressing drugs and immunomodulatory treatments may also influence host–microbe interactions, although their effects are difficult to separate from the disease being treated.

Local conditions may add practical complexity. A cat living in humid coastal Queensland may encounter different environmental fungal exposure than one in dry inland South Australia, although environmental exposure should not be confused with intestinal colonisation. Referral clinicians in Sydney, Melbourne or Brisbane may see complex cases where diet, polypharmacy and repeated antimicrobial courses overlap.

Interpreting fungal microbiome data

Faecal sequencing can describe microbial DNA, but detection does not prove viability, invasion or clinical importance. Results can vary according to collection, storage, extraction method and sequencing platform. A meaningful interpretation depends on validated reference ranges and a clear understanding of what the test can measure.

For this reason, fungal findings are best used as part of a longitudinal clinical picture. Repeated assessment, careful diet histories and documentation of medication exposure may reveal whether a pattern is stable, transient or associated with relapse. Collaboration with diagnostic laboratories is particularly important when results appear inconsistent with the cat’s condition.

Bringing mycobiome science into practice

A practical approach begins with stabilising the patient, confirming the major differential diagnoses and choosing a nutritionally complete diet that can be fed consistently. Monitoring body weight, faecal quality, appetite, vomiting and medication exposure provides a stronger foundation than trying to act on an isolated microbial result.

Veterinary teams can continue developing their knowledge through the ActivBiome learning hub, which includes expert-led education on the gut microbiome, chronic enteropathies and nutritional applications. Webinar content from researchers and institutions such as Harvard T.H. Chan School of Public Health, Texas A&M University and the University of Vienna helps place emerging fungal research within a broader clinical framework.

The feline gut mycobiome is still an evolving area, but it expands the clinical conversation beyond bacterial abundance alone. As methods improve, understanding fungal–bacterial interactions may help clarify why cats respond differently to diets, medications and treatments for chronic gastrointestinal disease.